Novel approaches to thrombolysis based on modulation of endogenous fibrinolysis.
Stefansson
S
S
American Red Cross, Holland Laboratory, Department of Biochemistry, Rockville, Maryland, USA.
Lawrence
D A
DA
Herren
T
T
Plow
E F
EF
D000818:Animals; D043424:Carboxypeptidase B; D002268:Carboxypeptidases / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000201:enzymology*; D005176:Factor XIII / Q000378:metabolism* / Q000627:therapeutic use; D005342:Fibrinolysis / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism* / Q000627:therapeutic use; D015842:Serine Proteinase Inhibitors / Q000378:metabolism* / Q000627:therapeutic use; D015912:Thrombolytic Therapy
D017395:Plasminogen Activator Inhibitor 1; D015842:Serine Proteinase Inhibitors; D005176:Factor XIII; D002268:Carboxypeptidases; D043424:Carboxypeptidase B